List of Tables
Table 1. Global Market Heart Failure Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Heart Failure Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Heart Failure Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Heart Failure Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Heart Failure Therapeutics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Heart Failure Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Heart Failure Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Heart Failure Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Heart Failure Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Heart Failure Therapeutics Revenue Market Share by Type (2024-2029)
Table 11. North America Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Heart Failure Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Heart Failure Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Heart Failure Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global Heart Failure Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Heart Failure Therapeutics Revenue Market Share by Application (2024-2029)
Table 26. North America Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Heart Failure Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Heart Failure Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Heart Failure Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Heart Failure Therapeutics Market
Table 40. Global Heart Failure Therapeutics Key Players Headquarters and Area Served
Table 41. Heart Failure Therapeutics Product Solution and Service
Table 42. Global Heart Failure Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bayer Basic Information List
Table 45. Bayer Description and Business Overview
Table 46. Bayer Heart Failure Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Heart Failure Therapeutics Business of Bayer (2018-2023)
Table 48. Bayer Recent Developments
Table 49. Cynokinetics Basic Information List
Table 50. Cynokinetics Description and Business Overview
Table 51. Cynokinetics Heart Failure Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Heart Failure Therapeutics Business of Cynokinetics (2018-2023)
Table 53. Cynokinetics Recent Developments
Table 54. Les Laboratoires Servier Basic Information List
Table 55. Les Laboratoires Servier Description and Business Overview
Table 56. Les Laboratoires Servier Heart Failure Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Heart Failure Therapeutics Business of Les Laboratoires Servier (2018-2023)
Table 58. Les Laboratoires Servier Recent Developments
Table 59. Merck & Co. Basic Information List
Table 60. Merck & Co. Description and Business Overview
Table 61. Merck & Co. Heart Failure Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Heart Failure Therapeutics Business of Merck & Co. (2018-2023)
Table 63. Merck & Co. Recent Developments
Table 64. Novartis Basic Information List
Table 65. Novartis Description and Business Overview
Table 66. Novartis Heart Failure Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Heart Failure Therapeutics Business of Novartis (2018-2023)
Table 68. Novartis Recent Developments
Table 69. Procoralan Basic Information List
Table 70. Procoralan Description and Business Overview
Table 71. Procoralan Heart Failure Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Heart Failure Therapeutics Business of Procoralan (2018-2023)
Table 73. Procoralan Recent Developments
Table 74. Bristol-Myers Squibb Company Basic Information List
Table 75. Bristol-Myers Squibb Company Description and Business Overview
Table 76. Bristol-Myers Squibb Company Heart Failure Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Heart Failure Therapeutics Business of Bristol-Myers Squibb Company (2018-2023)
Table 78. Bristol-Myers Squibb Company Recent Developments
Table 79. Cardiorentis AG Basic Information List
Table 80. Cardiorentis AG Description and Business Overview
Table 81. Cardiorentis AG Heart Failure Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Heart Failure Therapeutics Business of Cardiorentis AG (2018-2023)
Table 83. Cardiorentis AG Recent Developments
Table 84. CVie Therapeutics Limited Basic Information List
Table 85. CVie Therapeutics Limited Description and Business Overview
Table 86. CVie Therapeutics Limited Heart Failure Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Heart Failure Therapeutics Business of CVie Therapeutics Limited (2018-2023)
Table 88. CVie Therapeutics Limited Recent Developments
Table 89. Orion Corporation Basic Information List
Table 90. Orion Corporation Description and Business Overview
Table 91. Orion Corporation Heart Failure Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Heart Failure Therapeutics Business of Orion Corporation (2018-2023)
Table 93. Orion Corporation Recent Developments
Table 94. PhaseBio Pharmaceuticals Basic Information List
Table 95. PhaseBio Pharmaceuticals Description and Business Overview
Table 96. PhaseBio Pharmaceuticals Heart Failure Therapeutics Products, Services and Solutions
Table 97. Revenue (US$ Million) in Heart Failure Therapeutics Business of PhaseBio Pharmaceuticals (2018-2023)
Table 98. PhaseBio Pharmaceuticals Recent Developments
Table 99. Market Segment by Product Type Basic Information List
Table 100. Market Segment by Product Type Description and Business Overview
Table 101. Market Segment by Product Type Heart Failure Therapeutics Products, Services and Solutions
Table 102. Revenue (US$ Million) in Heart Failure Therapeutics Business of Market Segment by Product Type (2018-2023)
Table 103. Market Segment by Product Type Recent Developments
Table 104. B-Blockers Basic Information List
Table 105. B-Blockers Description and Business Overview
Table 106. B-Blockers Heart Failure Therapeutics Products, Services and Solutions
Table 107. Revenue (US$ Million) in Heart Failure Therapeutics Business of B-Blockers (2018-2023)
Table 108. B-Blockers Recent Developments
Table 109. Calcium Channel Blockers Basic Information List
Table 110. Calcium Channel Blockers Description and Business Overview
Table 111. Calcium Channel Blockers Heart Failure Therapeutics Products, Services and Solutions
Table 112. Revenue (US$ Million) in Heart Failure Therapeutics Business of Calcium Channel Blockers (2018-2023)
Table 113. Calcium Channel Blockers Recent Developments
Table 114. Cardiac Glycosides Basic Information List
Table 115. Cardiac Glycosides Description and Business Overview
Table 116. Cardiac Glycosides Heart Failure Therapeutics Products, Services and Solutions
Table 117. Revenue (US$ Million) in Heart Failure Therapeutics Business of Cardiac Glycosides (2018-2023)
Table 118. Cardiac Glycosides Recent Developments
Table 119. Diuretics Basic Information List
Table 120. Diuretics Description and Business Overview
Table 121. Diuretics Heart Failure Therapeutics Products, Services and Solutions
Table 122. Revenue (US$ Million) in Heart Failure Therapeutics Business of Diuretics (2018-2023)
Table 123. Diuretics Recent Developments
Table 124. Morphine Basic Information List
Table 125. Morphine Description and Business Overview
Table 126. Morphine Heart Failure Therapeutics Products, Services and Solutions
Table 127. Revenue (US$ Million) in Heart Failure Therapeutics Business of Morphine (2018-2023)
Table 128. Morphine Recent Developments
Table 129. Vasodilators/Nitrates Basic Information List
Table 130. Vasodilators/Nitrates Description and Business Overview
Table 131. Vasodilators/Nitrates Heart Failure Therapeutics Products, Services and Solutions
Table 132. Revenue (US$ Million) in Heart Failure Therapeutics Business of Vasodilators/Nitrates (2018-2023)
Table 133. Vasodilators/Nitrates Recent Developments
Table 134. North America Heart Failure Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 135. North America Heart Failure Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 136. Europe Heart Failure Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 137. Europe Heart Failure Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 138. Asia-Pacific Heart Failure Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 139. Asia-Pacific Heart Failure Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 140. Asia-Pacific Heart Failure Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 141. Asia-Pacific Heart Failure Therapeutics Market Share by Region (2018-2023)
Table 142. Asia-Pacific Heart Failure Therapeutics Market Share by Region (2024-2029)
Table 143. Latin America Heart Failure Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 144. Latin America Heart Failure Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 145. Latin America Heart Failure Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 146. Middle East & Africa Heart Failure Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 147. Middle East & Africa Heart Failure Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 148. Middle East & Africa Heart Failure Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 149. Heart Failure Therapeutics Market Trends
Table 150. Heart Failure Therapeutics Market Drivers
Table 151. Heart Failure Therapeutics Market Challenges
Table 152. Heart Failure Therapeutics Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Heart Failure Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Heart Failure Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Heart Failure Therapeutics Market Share by Regions: 2022 VS 2029
Figure 4. Global Heart Failure Therapeutics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Diagnosis
Figure 11. Global Diagnosis Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Prognosis
Figure 13. Global Prognosis Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Treatment Options and Treatment Algorithm
Figure 15. Global Treatment Options and Treatment Algorithm Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global Heart Failure Therapeutics Market Size Share by Type: 2022 & 2029
Figure 17. North America Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
Figure 18. Europe Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
Figure 20. Latin America Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
Figure 22. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Clinic Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Medical Research Organization Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Global Heart Failure Therapeutics Market Size Share by Application: 2022 & 2029
Figure 26. North America Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
Figure 27. Europe Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
Figure 28. Asia-Pacific Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
Figure 29. Latin America Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
Figure 30. Middle East and Africa Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
Figure 31. Heart Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Heart Failure Therapeutics Market Share in 2022
Figure 33. North America Heart Failure Therapeutics Market Share by Country (2018-2029)
Figure 34. U.S. Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 35. Canada Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 36. Germany Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 37. France Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 38. U.K. Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 39. Italy Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 40. Russia Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 41. Nordic Countries Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 42. Asia-Pacific Heart Failure Therapeutics Market Share by Region (2018-2029)
Figure 43. China Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 44. Japan Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 45. South Korea Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 47. India Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 48. Australia Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 49. Latin America Heart Failure Therapeutics Market Share by Country (2018-2029)
Figure 50. Mexico Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 51. Brazil Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Heart Failure Therapeutics Market Share by Country (2018-2029)
Figure 53. Turkey Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 55. UAE Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report